This message was sent to ##Email## November 30, 2016     Home  |   About   Subscribe  |   Archive  |   Advertise   Primary cytoreductive surgery associated with improved survival in ovarian cancer Oncology Nurse Advisor Primary cytoreductive surgery was associated with improved survival compared with neoadjuvant chemotherapy in otherwise healthy women age 70 years or younger with advanced-stage epithelial ovarian cancer, according to findings published in JAMA Oncology. Because the benefits of primary cytoreductive surgery relative to neoadjuvant chemotherapy remain uncertain, researchers sought to compare overall survival of primary cytoreductive surgery with that of neoadjuvant chemotherapy in a large national population of women with advanced-stage epithelial ovarian cancer.  READ MORE    SPONSORED CONTENT Promoted by CHAMPS Oncology CHAMPS i2o® Cancer Analytics Answer Questions About Your Service Line i2o® Provides Cancer Center Administrators with Customized Infographic Evaluate the Quality and Validity of Your Registry Data insight2oncology® Offers New Perspective of Your Current Market Position CHAMPS insight2oncology® and i2o® Receive Registered Trademark   RT after surgery boosts survival in prostate cancer with lymph node involvement Cancer Network The use of radiotherapy (RT) was associated with an overall survival benefit in patients with prostate cancer and lymph node involvement who underwent radical prostatectomy and were also treated with androgen-deprivation therapy, according to a new study. Approximately 12 percent of prostate adenocarcinoma patients have regional lymph node involvement at diagnosis.  READ MORE Targeting breast cancer metabolism to fight the disease Medical Xpress How does a cancer cell burn calories? New research from Thomas Jefferson University shows that breast cancer cells rely on a different process for turning fuel into energy than normal cells. The results were recently published in the Journal of Biological Chemistry. "Our finding is part of a growing interest in studying the metabolic function of cancer," says Ubaldo Martinez-Outschoorn, M.D., assistant professor in the Department of Medical Oncology at Thomas Jefferson University and researcher at the Sidney Kimmel Cancer Center at Jefferson. "The better we understand how cancers thrive, the better we'll be able to cut off the energy supply they need for survival."  READ MORE    PRODUCT SHOWCASE Advertisement Wiley's Oncology Apps Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. NCCN challenges medical community to 'Just Bag It' to eradicate deadly medical error NCCN As part of its mission to improve the quality, effectiveness and efficiency of cancer care so that patients can live better lives, the National Comprehensive Cancer Network® (NCCN®) has announced the launch of Just Bag It: The NCCN Campaign for Safe Vincristine Handling. This campaign encourages healthcare providers to adopt a policy to always dilute and administer vincristine in a mini-intravenous (IV) drip bag to prevent a particular deadly medical error.  READ MORE AJCC Cancer Staging Manual, 8th edition The American Joint Committee on Cancer (AJCC) has released the eighth edition of its Cancer Staging Manual. This edition presents evidence‐based revisions for staging cancer for a number of organ sites and includes the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis (TNM); stage groupings; and histologic grade. The new publication can be purchased online at www.cancerstaging.org.    SPONSORED CONTENT Promoted by InformedDNA Practitioners peddle unneeded genetic tests, supplements Gynecologic oncologists release genetics toolkit for patients, providers InformedDNA CMO is guided by experience as a cancer researcher and survivor Family medical history is the first step to identifying carrier status InformedDNA FREE Webinar: Learn How to "Strengthen Your Practice with Genetic Counseling"-Click Here to Register!   Squamous cell carcinoma of lip predominantly affects white men in their mid-60s MedicalResearch.com Researchers: Squamous cell carcinoma (SCC) of the lip makes up a large portion of oral cancers (25 percent). Most of the demographic and prognostic indicators for lip SCC are only available through retrospective case series. Thus, we used the national cancer database (Surveillance, Epidemiology and End Results, or SEER) to examine the incidence, treatment and survival of patients with lip SCC.  READ MORE .  PRODUCT SHOWCASE prIME Patients by prIME Oncology prIME Patients is prIME Oncology’s resource center for patients with cancer and their caregivers. Our patient-focused videos explain, in layman’s terms, how certain treatments fight the various cancers. This information will arm you with the knowledge on what to expect during your course treatment so that you can be an informed part of the decision making team. ASCO and ONS release updated chemotherapy administration standards that now includes pediatric care ASCO ASCO and the Oncology Nursing Society (ONS) have updated their chemotherapy administration safety standards to include pediatric oncology care. The updated standards can be found in the Journal of Oncology Practice. In 2009, ASCO and ONS published the initial set of standards for safely administering chemotherapy in the outpatient setting. The standards were updated in 2011 to include inpatient facilities and again in 2013 to include safe oral chemotherapy administration and management.  READ MORE     .  SPONSOR SPOTLIGHT     New insight into why leukemia drug is successful Medical Xpress Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukemia. Chronic lymphocytic leukemia (CLL) is the most common form of leukemia, with more than 4,000 cases in the U.K. every year. At the moment CLL is incurable, but in recent years, new drugs called B-cell receptor inhibitors have revolutionized treatment.  READ MORE Announcing the Commission on Cancer 2016-2017 cancer research paper competition for physicians-in-training CoC The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30, 2017.  READ MORE    TRENDING ARTICLES Missed last week's issue? See which articles your colleagues read most. Resistance training improves posttreatment outcomes for breast cancer survivors (Oncology Nurse Advisor) Immunotherapy is curing lung cancer — who is a candidate? (Forbes) ASCO launches oncology medical home model (Medscape) Does dose-dense chemotherapy improve outcomes for patients with high-risk early breast cancer? (Cancer Therapy Advisor) Older patients can benefit from lung cancer surgery (NPR) Don't be left behind. Click here to see what else you missed.   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Whipple, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063